8-KThe WireRoutine
Bylaw Amendment
Filed Mar 3, 2023 · 3y ago · Accession 0001193125-23-060031
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- AGIOS PHARMACEUTICALS, INC.
- Ticker
- AGIO
- CIK
- 1439222
- Form type
- 8-K
- Filing date
- Mar 3, 2023
- Report date
- Mar 2, 2023
- Document
- d638020d8k.htm
- Size
- 301 KB